Meta-analysis of percutaneous radiofrequency ablation versus ethanol injection in hepatocellular carcinoma.
about
Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinomaRadiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinomaNew advances in hepatocellular carcinomaCancer and liver cirrhosis: implications on prognosis and managementRole of local ablative therapy for hepatocellular carcinomaRadiofrequency ablation of hepatocellular carcinoma: a literature reviewRadiofrequency ablation of hepatocellular carcinoma: Current statusSurvivin downregulation using siRNA nanoliposomes inhibits cell proliferation and promotes the apoptosis of MHCC-97H hepatic cancer cells: An in vitro and in vivo study.Meta-analysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma.Role of radiofrequency ablation in patients with hepatocellular carcinoma who undergo prior transarterial chemoembolization: long-term outcomes and predictive factors.Prognostic prediction across a gradient of total tumor volume in patients with hepatocellular carcinoma undergoing locoregional therapyHigh-dose stereotactic body radiotherapy correlates increased local control and overall survival in patients with inoperable hepatocellular carcinoma.RETRACTED: Systematic evaluation of percutaneous radiofrequency ablation versus percutaneous ethanol injection for the treatment of small hepatocellular carcinoma: a meta-analysisSystematic review of radiofrequency ablation versus percutaneous ethanol injection for small hepatocellular carcinoma up to 3 cm.The Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The Puri Recommendations.Radiofrequency ablation versus percutaneous ethanol injection for hepatocellular carcinoma: a meta-analysis of randomized controlled trialsEthanol injection is highly effective for hepatocellular carcinoma smaller than 2 cm.Hepatocellular carcinoma: Advances in diagnosis, management, and long term outcome.Treatment of uterine myomas by radiofrequency thermal ablation: a 10-year retrospective cohort study.Management of hepatocellular carcinoma: an overview of major findings from meta-analysesRadiofrequency ablation combined with percutaneous ethanol injection for hepatocellular carcinoma: a systematic review and meta-analysis.Hepatocellular carcinoma: natural history, current management, and emerging tools.Impact of Radiofrequency Ablation-Induced Glisson's Capsule-Associated Complications in Patients with Hepatocellular Carcinoma.Therapeutic efficacy and safety of percutaneous ethanol injection with or without combined radiofrequency ablation for hepatocellular carcinomas in high risk locationsCurrent oncologic applications of radiofrequency ablation therapies.Management of hepatocellular carcinoma: Enlightening the gray zones.Percutaneous radiofrequency ablation versus surgical radiofrequency ablation for malignant liver tumours: the long-term results.Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeuticsPercutaneous radiofrequency ablation for early hepatocellular carcinoma: risk factors for survival.CT-guided versus laparoscopic radiofrequency ablation in recurrent small hepatocellular carcinoma against the diaphragmatic domeLoco-regional treatment of hepatocellular carcinoma.Surgical treatment of hepatocellular carcinoma: expert consensus statement.Is it time to reconsider the BCLC/AASLD therapeutic flow-chart?Current status of radiofrequency ablation of hepatocellular carcinoma.Treatment options in hepatocellular carcinoma today.The current role of minimally invasive therapies in the management of liver tumors.Mortality and complication rates of percutaneous ablative techniques for the treatment of liver tumors: a systematic review.Irreversible electroporation for unresectable hepatocellular carcinoma: initial experience and review of safety and outcomes.Treatment of hepatocellular carcinoma: a systematic review.Image-guided ablation of primary liver and renal tumours.
P2860
Q24186496-D1BCBF22-F576-4BD8-87CE-792FC1A74471Q24201669-A773531F-6CEB-447C-95A5-0605CC4BB496Q26749329-3E0B41E7-02D9-4651-8CC5-C84DF3B62F36Q28068579-8740951F-3CEF-4562-B13C-3A4D0A20DC24Q30417048-24FED416-694C-4229-B386-49897877DAD3Q30473747-0096ABBD-C112-4A9E-AD45-8402B84A8BE9Q30478030-DF287356-527F-4016-B474-A87775441580Q32178045-257F7DF5-D73F-46B4-BE29-6CD4CBF687B3Q33629394-354B3539-46BD-48C0-9D56-50EDDFEA09F4Q34182112-B62A4568-ABF4-4E9B-BC2F-E7A6BA02AFDBQ34498762-53AA06BF-6439-474E-B47F-2701B2FD6918Q34508914-B8D2CB40-4F21-4CC0-82A2-0377CC2EDE6FQ34544494-3C78A2CA-4143-4C50-BA9E-7F7B0A4AA321Q34595503-B9765ECA-DBEB-4A22-A7F9-67739D05ACBFQ34826535-3100C383-D9B0-4795-BD47-F10E9E2E2572Q35166558-779FEAB6-9A71-4E2A-9B0A-3924A044C306Q35171592-83D024DD-C70E-4CA9-8927-47DF3B8328D6Q35626757-196132DC-3D31-4B22-86CC-9B7549CD6082Q35902122-FB3E5AF6-7361-484F-81CD-04A054D0AE7DQ36014255-A9DD6E6E-0AA7-4280-8DCD-69DA9C59E0FAQ36152907-A464517B-ADB0-4DEA-B1A2-5EE3590CCB27Q36171275-634920E0-9903-4A99-8D69-6A196A98D06DQ36252639-5DBECF01-3616-4E1F-8371-23BEEE975F62Q36662565-DCF6E214-EC3E-4C59-97ED-517F2528BF96Q36828555-BDDCE690-A025-40DE-8DC8-B42645AFA6C3Q36955647-448B3FE4-D83E-4FB6-B5F8-E3B4BC1A3DF6Q37064699-8377E24A-08FE-42D0-A972-25993E372936Q37355835-D65EDE27-1F2F-46A9-B10A-C75BB67392D4Q37587279-FDC7DDE8-1EB6-47DD-AA1C-3EABE8080B84Q37698738-E452464D-9BBB-4CA5-A261-01510E6DD73BQ37766546-89487493-B1DA-4541-8202-5D1763437A9FQ37768894-A6843548-5291-44FB-B8A0-A736F3314F90Q37795703-D6709B9E-4E82-4F67-95B7-B507C08321B7Q37821277-F7AADEA1-D65B-46E8-9A92-F80990CE6775Q37863929-4F185D8F-AC44-4667-A948-4E4051B1DA31Q37874475-46441A29-C274-4F4D-8098-8FBF4245E7E6Q37920769-99BB1AF0-C1ED-4A95-82FF-6374390BC235Q38078075-741D2079-7609-41AA-AE2D-2FD67D3963F8Q38155508-15C40C63-4CDA-4E18-90D4-1E70991B399BQ38324277-CB406756-1CB8-40D4-B1E7-D0475B128F70
P2860
Meta-analysis of percutaneous radiofrequency ablation versus ethanol injection in hepatocellular carcinoma.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Meta-analysis of percutaneous ...... n in hepatocellular carcinoma.
@ast
Meta-analysis of percutaneous ...... n in hepatocellular carcinoma.
@en
type
label
Meta-analysis of percutaneous ...... n in hepatocellular carcinoma.
@ast
Meta-analysis of percutaneous ...... n in hepatocellular carcinoma.
@en
prefLabel
Meta-analysis of percutaneous ...... n in hepatocellular carcinoma.
@ast
Meta-analysis of percutaneous ...... n in hepatocellular carcinoma.
@en
P2093
P2860
P31
P921
P356
P1433
P1476
Meta-analysis of percutaneous ...... n in hepatocellular carcinoma.
@en
P2093
Carmen Bouza
José María Amate
Raimundo Alcázar
Zuleika Saz-Parkinson
P2860
P2888
P356
10.1186/1471-230X-9-31
P5008
P577
2009-05-11T00:00:00Z
P6179
1002692483